Vaccine

Eli Lilly to Pursue mRNA Cancer Vaccines with CureVac Pact

One year ago   |   By Xconomy

Eli Lilly is getting a foothold in messenger RNA cancer vaccines through a deal with CureVac that could develop up to five new therapies. Indianapolis-based Lilly will pay CureVac, headquarted in Germany, $50 million up front, plus make an equity investment in the company valued at nearly $53 million, according to the agreement announced Wednesday. The deal calls for CureVac to use its proprietary technology to design, formulate, and manufacture the vaccine candidates. Lilly will handle clinical testing, and if approved, oversee commercialization of the drugs. If all five vaccines reach...
Read more ...

 

Lilly, CureVac pen $1.8B mRNA cancer vaccine deal

Lilly, CureVac pen $1.8B mRNA cancer vaccine deal

One year ago   |   By Fierce Biotech

Eli Lilly is putting up $1.8 billion to work with CureVac on five mRNA cancer vaccines. The back-loaded deal moves Lilly into an emerging field that seeks to use mRNA to guide immune attacks on tumors.
Read more ...

 


Search by Tags

   Vaccine      Vaccines      Therapies      Drugs      Drug      Cancer      Manufacturing      Clinical      RNA      Boston blog main      Indiana      Indiana blog main      Indiana top stories      National blog main      Abemaciclib      Bill & Melinda Gates Foundation      BioNtech      Biotech      Boehringer Ingelheim      Cancer      Cancer vaccines      Clinical trials      CureVac      Eli Lilly      FDA      Food and Drug Administration      International AIDS Vaccine Initiative      Life Sciences      ModeRNA Therapeutics      MRNA      RaNA Therapeutics      Sanofi      Immunity  


2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

14th International Conference on Generic Drugs and Biosimilars

Conference series takes pleasure in inviting the scientific community across the globe to attend the 14th International Conference on Generic Drugs & Biosimilars during... Read more ...

14th International Conference on Generic Drugs and Biosimilars

14th International Conference on Generic Drugs and Biosimilars November 15-16, 2018 | Berlin, Germany Best Western Premier Airporthotel Fontane Berlin Theme: A new Era in... Read more ...

Patient Centered Communication and e-health information exchange patterns...

Patient Centered Communication and e-health information exchange patterns: Findings from a National Cross-Sectional Survey

Onur Asan , Bradley Crotty , Sneha Nagavally , Leonard Egede Early Access Note: Early Access articles are new content made available in advance of the final electronic or print... Read more ...

San Diego Tallies 7 IPOs in Best Year For Market Debuts Since 2014

San Diego Tallies 7 IPOs in Best Year For Market Debuts Since 2014

Will “CBUS” and “SI” join “THOR” and “RMED”? It's next week or never for two San Diego companies that have filed documents with securities regulators indicating plans to go... Read more ...

With Losses Mounting, MabVax Therapeutics Looks to Sell Off Assets

With Losses Mounting, MabVax Therapeutics Looks to Sell Off Assets

MabVax Therapeutics says it doesn't have enough money to continue funding its operations. The San Diego biotech company, which is testing an antibody discovery platform... Read more ...

Closure comes with final defense

Closure comes with final defense

Ph.D. dissertation wraps up student career. By Erica Overfelt | Bond LSC Ending your career as a student is a whirlwind of emotion. Ph.D. student Ben Spears soon will be saying... Read more ...

DataCloud Raises $4M to Guide Miners' Drilling, Blasting Decisions

DataCloud Raises $4M to Guide Miners' Drilling, Blasting Decisions

DataCloud , a developer of sensors and software to help guide mine operators' decision-making around drilling and blasting, has raised $4 million in new financing to support... Read more ...

Emotional Intelligence Startup Cogito Spins Out Mental Health Unit

Emotional Intelligence Startup Cogito Spins Out Mental Health Unit

Cogito, the A.I. startup that wrings emotional intelligence cues out of the human voice, is training its focus on call centers and splitting off its behavioral health unit into... Read more ...

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO Comments on Objectives for U.S. Japan Trade Agreement

BIO supports the U.S. Trade Representative's negotiations with the Government of Japan as an opportunity to grow U.S. exports and create U.S. jobs. We would strongly urge the... Read more ...

Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition

Merck Beefs Up Animal Health Unit with $2.4B Antelliq Acquisition

Merck has agreed to pay nearly $2.4 billion to acquire Antelliq Group , a privately held French company that makes devices used in monitoring and tracking animals. In addition... Read more ...

Rectify Takes Its Lengthy History to San Antonio Security Incubator

Rectify Takes Its Lengthy History to San Antonio Security Incubator

San Antonio -Rectify, a business developing software to automate the process of removing private or sensitive information from documents when they're shared, has had a busy... Read more ...

U-M's Desai Accelerator Invests Millionth Dollar Since 2013 Launch

U-M's Desai Accelerator Invests Millionth Dollar Since 2013 Launch

The University of Michigan's Desai Accelerator , an incubator open to early-stage tech startups regardless of their connection to the school, hit a major milestone this year... Read more ...